FDA Warns of Possible Heart Failure Risk with Pramipexole

The FDA is investigating the possibility that pramipexole (Mirapex) increases the risk for heart failure. In a pooled analysis of randomized trials, t...

To continue reading, please log in to the right or request an invitation.